| 来源类型 | Discussion paper |
| 规范类型 | 论文 |
| 来源ID | DP17293 |
| DP17293 Bargaining and International Reference Pricing in the Pharmaceutical Industry | |
| Pierre Dubois; Shoshana Vasserman | |
| 发表日期 | 2022-05-10 |
| 出版年 | 2022 |
| 语种 | 英语 |
| 摘要 | The United States spends twice as much per person on pharmaceuticals as European countries, in large part because prices are much higher in the US. This fact has led policymakers to consider legislation for price controls. This paper assesses the effects of a US international reference pricing policy that would cap prices in US markets by those offered in reference countries. We estimate a structural model of demand and supply for pharmaceuticals in the US and reference countries like Canada where prices are set through a negotiation process between pharmaceutical companies and the government. We then simulate the counterfactual equilibrium under such international reference pricing rules, allowing firms to internalize the cross-country externalities introduced by these policies. We find that in general, these policies would result in much smaller price decreases in the US than price increases in reference countries. The magnitude of these effects depends on the number, size and market structure of references countries. We compare these policies with a direct bargaining on prices in the US. |
| 主题 | Industrial Organization |
| 关键词 | Pharmaceuticals International reference pricing Bargaining Empirical industrial organization |
| URL | https://cepr.org/publications/dp17293 |
| 来源智库 | Centre for Economic Policy Research (United Kingdom) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/546316 |
| 推荐引用方式 GB/T 7714 | Pierre Dubois,Shoshana Vasserman. DP17293 Bargaining and International Reference Pricing in the Pharmaceutical Industry. 2022. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
